Market Report, "Puerto Rico Pharmaceuticals & Healthcare Report Q4 2015", published

While the forecast for Puerto Rico has remained at a stable trajectory, the US territory is facing an uncertain future, caused by United States congressional healthcare decisions that much of the island's population feel will lead to widespread economic harm. In addition to this, Puerto Rico's reputation as being a hub of pharmaceutical and biotech manufacturing is in jeopardy due to changes to US laws that protected multinational manufacturing companies based there from US taxes.

Headline Expenditure Projections

Pharmaceuticals: USD3.02bn in 2014 to USD3.03bn in 2015; 0.40%. Forecast up compared with Q 3 1 5 .
Healthcare: USD7.79bn in 2014 to USD8.07bn in 2015; +3.7%. Forecast unchanged since Q 3 1 5 .

Risk/Reward Index

Puerto Rico is the third most attractive pharmaceutical market in the Americas region, behind the US and Canada. Puerto Rico's Pharmaceutical Risk/Reward Index score of 62.6 out of 100 is 1.8 points lower than in Q115, the result of a decrease in the rewards aspect of the index. Puerto Rico's position will remain threatened by rising scores from Brazil, Mexico, Argentina and Colombia, given their lower operating costs and improving business environments. Globally, Puerto Rico ranks highly in terms of its business environment, largely due to its sophisticated intellectual protection laws and political stability, although its uncompetitive labour force has increasingly come under scrutiny.

Full Report Details at
- http://www.fastmr.com/prod/1038336_puerto_rico_pharmaceuticals.aspx?afid=301

Key Trends And Developments

The Puerto Rico Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Puerto Rico Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Puerto Rico pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Puerto Rico, to test other views - a key input for successful budgeting and strategic business planning in the Puerto Rican pharmaceutical and healthcare market.
* Target business opportunities and risks in the Puerto Rican pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Puerto Rico.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Nigeria Pharmaceuticals & Healthcare Report Q4 2015